Q’Apel Medical Armadillo SelectFlex Neurovascular Access System Approved in Europe

January 13, 2025—Q’Apel Medical announced it has received CE Mark certification for its Armadillo SelectFlex neurovascular access system.

According to the company, Armadillo SelectFlex is indicated for the introduction of interventional devices into the neurovasculature. The low-profile 7-F catheter enables a biaxial approach, regardless of access site, to accelerate delicate interventions and eliminate the complexity and cost of a conventional triaxial configuration.

The Q’Apel SelectFlex technology is intended to allow a balance of trackability and support-on-demand to navigate complex anatomy, noted the press release.

“Neurovascular access can be extremely challenging,” commented Pascal Jabbour, MD, in the company’s press release. “The tortuous anatomy requires flexibility to navigate the tight twists and turns; however, flexible access catheters tend to lack the support and stability required for device delivery once positioned.”

Dr. Jabbour continued, “Armadillo provides a one-and-done solution that simplifies access procedures. It is designed to place full control in the hands of the operator as it allows users to transform the catheter from highly trackable to highly supportive as needed throughout the procedure, with the simple injection or withdrawal of just 0.2 mL of saline.”

Dr. Jabbour is The Angela and Richard T. Clark Distinguished Professor of Neurological Surgery and Radiology, Division Chief of Neurovascular Surgery & Endovascular Neurosurgery at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania.